FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: Is FTY720 the next autophagy-blocking agent in lymphoma treatment?

Autophagy

Volumn 8, Issue 3, 2012, Pages 416-417

  Alinari, Lapo ^a   Baiocchi, Robert A ^a   Prætorius Ibba, Mette ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autophagy; FTY720; Lysosomal cell death; Mantle cell lymphoma; Milatuzumab

Indexed keywords

CD74 ANTIGEN; FINGOLIMOD; LC3 II PROTEIN; MILATUZUMAB; PROTEIN; PROTEIN P63; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOLYSOSOME; AUTOPHAGY; CANCER CELL; CANCER CELL DESTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFICACY; DRUG POTENTIATION; DRUG TARGETING; HOMEOSTASIS; HUMAN; MANTLE CELL LYMPHOMA; NONHUMAN; OVARY CANCER; SHORT SURVEY;

EID: 84859149451     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.19050     Document Type: Short Survey

References (0)